MRD / Regn No. : THBC\23-24\01829 Date : 21/07/2026
Patient Name : Raju More Age & Gender : 57 Yrs. / Male
Contact No. : 9821646743 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (05/Jul/2012) |
Subjective : T2DM SINCE 2012,REC UTI WITH SGLT2 INHIBITOR,PDR - DR SARVESH TIWARI,MICRO-MACROALB - NO RESPONSE TO KERENDIA - CREAT INCR TO 1.4 / POTASSIUM 6.65,FREQ OF URINATION - 4-5 TIMES/NIGHT,DID NOT TOLERATE ALFUZOSIN - TRYING SILODOSIN
Objective : 21-JUL-2026 REPORTS,ACR-322.84,FBS-161.1/ PPBS-356.1,HBA1C-10.6%
Plan : STOP RAMCOR / START TELMISARTAN 40 MG - CHECK BP - IF NORMAL INCREASE DOSE TO 80 MG,CHECK SERUM CREAT . POTASSIUM IF DOSE IS 80 MG,DID NOT TOLERATE ALFUZOSIN - WILL TRY SILODOSIN  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET TENELIGLIPTIN 20MG
TENDIA 20 MG
ORAL 1-0-0 ABF
4 MTHS
2 ROZUCOR F ORAL 0-0-1 AD
4 MTHS
3 TABLET CHOLECALCIFEROL
DRISE 60,000
ORAL 1/30 DAYS ANYTIME OF DAY
4 MTHS
4 VOGLOYD 0.2 ORAL 0-1-0 WITH LUNCH
4 MTHS
5 RECLIMET OD 60+500 MG ORAL 1/2-0-1/2 BBF
4 MTHS
6 SILODOL D 8 MG ORAL 0-0-1 AD
3 MTHS
7 TABLET TELMISARTAN 40MG
ERITEL 40 MG
ORAL 1-0-0 ABF
3 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit :
Tests Suggested For Next Visit : 10 DAYS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: